Enthera Srl News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Enthera Pharmaceuticals Appoints Lisa M Olson as CEO and Announces Clinical Trial Progress with Ent001
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Enthera Pharmaceuticals Initiates Phase 1 Clinical Trial with Lead Candidate Ent001
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Enthera Pharmaceuticals Appoints Filippo Canducci as Chief Medical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
News - Verzenio, Switzerland
thepharmaletter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thepharmaletter.com Daily Mail and Mail on Sunday newspapers.
Enthera Pharmaceuticals Extends Series A Financing, Raising a Total Of €35m
Funds to be used to advance restorative therapy for type 1 diabetes and inflammatory bowel disease
Largest international VC-backed Series A financing round for a biotech in Italy to date and first ever venture investment in an Italian company by both AbbVie Ventures and Roche Venture Fund
Proceeds to be used for clinical proof-of-concept for lead product Ent001 (IGFBP3/TMEM219 inhibitor) for type 1 diabetes, gastrointestinal diseases and progress pipeline assets
Enthera Pharmaceuticals ( Enthera ), a biotech company developing disease-modifying biologics to transform the therapeutic paradigm of specific autoimmune conditions by re-establishing stem cell capabilities in a non-traditional way, today announces the final closing of its Series A financing, with a total financing of €35m.